Top 10 Companies in the (R)-N-Benzyl-3-hydroxypyrrolidine (CAS 101930-07-8) Market (2026): Market Leaders Shaping Global Supply

MARKET INSIGHTS

Global (R)-N-Benzyl-3-hydroxypyrrolidine (CAS 101930-07-8) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting an annual growth rate of 6.4% during the forecast period.

(R)-N-Benzyl-3-hydroxypyrrolidine is a chiral pyrrolidine derivative with the molecular formula C₁₁H₁₅NO, widely recognized as a versatile building block in asymmetric synthesis and pharmaceutical development. The compound features a hydroxyl group at the 3‑position of the pyrrolidine ring in the (R)-configuration, making it particularly valuable for the stereoselective synthesis of biologically active molecules. Its structural attributes lend themselves to applications in the preparation of CNS‑active agents, antiviral compounds, and other therapeutically relevant intermediates.

The market is gaining steady momentum, primarily fueled by the expanding demand for enantiomerically pure intermediates in drug discovery and the growing emphasis on green chemistry practices within the fine chemicals sector. Increased R&D activity across contract research organizations and pharmaceutical manufacturers reinforces procurement of high‑purity chiral building blocks such as (R)-N-Benzyl-3‑hydroxypyrrolidine. Key suppliers operating in this space include TCI Chemicals, Sigma‑Aldrich (Merck KGaA), AstaTech Inc., and Combi‑Blocks, all of whom maintain active catalog listings for this compound to serve global research and production needs.

(R)-N-Benzyl-3-hydroxypyrrolidine (CAS 101930-07-8) Market – View in Detailed Research Report

🔟 10. Synthonix Inc.

Headquarters: San Diego, California, USA
Key Offering: Custom synthesis of chiral pyrrolidine intermediates

Synthonix specializes in rapid, small‑batch production of high‑purity chiral building blocks for early‑stage drug discovery. Its modular synthesis platform reduces lead times, allowing CROs to iterate quickly on lead optimization.

Sustainability Initiatives:

• Implementation of solvent‑free catalytic routes
• Partnerships with renewable energy suppliers for laboratory operations
• Continuous improvement of waste‑to‑energy processes

🧩 9. Oakwood Chemical

Headquarters: Chicago, Illinois, USA
Key Offering: Large‑scale production of pharmaceutical‑grade intermediates

Oakwood Chemical leverages its extensive manufacturing footprint to deliver consistent quality and volume. The company focuses on process optimization to maintain optical purity while scaling production.

Sustainability Initiatives:

• Adoption of green chemistry metrics across all sites
• Investment in carbon‑capture technology for synthesis units
• Certification of ISO 14001 environmental management

🔹 8. Ambeed Inc.

Headquarters: Austin, Texas, USA
Key Offering: Rapid prototyping and scale‑up services for chiral intermediates

Ambeed provides end‑to‑end solutions from laboratory synthesis to pilot‑scale production, enabling clients to transition from discovery to commercial manufacturing with minimal friction.

Sustainability Initiatives:

• Implementation of energy‑efficient reactors
• Use of bio‑derived solvents in synthesis processes
• Transparent reporting of life‑cycle environmental impact

🔸 7. Combi‑Blocks Inc.

Headquarters: New York, New York, USA
Key Offering: High‑purity chiral building blocks with rapid turnaround

Combi‑Blocks focuses on delivering quality and speed to pharmaceutical manufacturers and CROs. Its proprietary synthesis routes minimize by‑product formation, ensuring consistent optical purity.

Sustainability Initiatives:

• Development of recyclable catalyst systems
• Reduction of hazardous waste through process redesign
• Participation in industry green‑chemistry consortiums

🛠️ 6. Tokyo Chemical Industry Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: High‑purity chiral intermediates for CNS therapeutics

Tokyo Chemical Industry maintains a strong foothold in the high‑purity segment, offering rigorous quality control and compliance with international regulatory standards.

Sustainability Initiatives:

• Investment in renewable energy for production facilities
• Implementation of closed‑loop solvent recovery systems
• Active collaboration with academia on green‑synthesis research

⚙️ 5. Enamine LLC

Headquarters: Lviv, Ukraine
Key Offering: Custom synthesis of chiral pyrrolidine intermediates

Enamine leverages its advanced asymmetric catalysis expertise to deliver tailored solutions for R&D laboratories and small‑to‑medium manufacturers.

Sustainability Initiatives:

• Adoption of biocatalytic processes to reduce solvent use
• Engagement in circular economy initiatives for chemical waste
• Certification of green chemistry practices across laboratories

🔬 4. Biosynth Carbosynth

Headquarters: Zurich, Switzerland
Key Offering: High‑value, low‑volume synthesis for R&D demands

Biosynth Carbosynth focuses on delivering complex chiral molecules with rapid turnaround, supporting academic and industrial research projects worldwide.

Sustainability Initiatives:

• Implementation of green solvent alternatives
• Optimization of reaction conditions to reduce energy consumption
• Participation in European chemical sustainability networks

💡 3. Capot Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Large‑scale production of pharmaceutical intermediates

Capot Chemical combines cost‑effective manufacturing with stringent quality controls, serving a broad portfolio of chiral intermediates for the Asian market.

Sustainability Initiatives:

• Investment in green‑energy infrastructure for production plants
• Implementation of waste‑to‑energy conversion systems
• Compliance with China’s national environmental regulations

🌐 2. Hairui Fine Chemicals Co., Ltd.

Headquarters: Nanjing, China
Key Offering: High‑purity chiral intermediates with rapid supply

Hairui Fine Chemicals has established a reputation for delivering consistent optical purity at scale, supported by advanced chiral resolution technologies.

Sustainability Initiatives:

• Adoption of renewable energy sources for manufacturing
• Implementation of green‑chemistry protocols across all sites
• Active engagement in China’s chemical industry sustainability forums

🏆 1. Pharmablock Sciences Co., Ltd.

Headquarters: Suzhou, China
Key Offering: Comprehensive supply of chiral building blocks for CNS therapeutics

Pharmablock Sciences dominates the market with a robust production network and a portfolio that includes high‑purity (R)-N-Benzyl-3-hydroxypyrrolidine. Its focus on quality compliance and supply chain resilience positions it as a preferred partner for large‑scale API manufacturers.

Sustainability Initiatives:

• Integration of renewable energy in manufacturing processes
• Implementation of closed‑loop solvent recycling systems
• Active participation in global green‑chemistry initiatives

Download FREE Sample Report

Get Full Report

🌍 Outlook: The Future of (R)-N-Benzyl-3-hydroxypyrrolidine Market

As pharmaceutical development increasingly prioritizes stereochemical precision, demand for enantiomerically pure intermediates such as (R)-N-Benzyl-3-hydroxypyrrolidine is set to rise. The compound’s role in CNS‑active agents, antiviral agents, and other therapeutic classes will continue to drive procurement, especially as new drug candidates enter late‑stage development. Concurrently, regulatory frameworks that enforce stringent purity standards will reinforce the need for high‑quality chiral building blocks, ensuring that suppliers with robust quality systems maintain a competitive edge.

📈 Key Trends Shaping the Market:

• Expansion of CNS‑focused drug pipelines, amplifying the need for chiral intermediates.
• Adoption of biocatalytic and green‑synthesis routes to reduce environmental impact.
• Growth in custom synthesis services driven by R&D requirements.
• Consolidation among mid‑sized manufacturers seeking scale and quality alignment.
• Increasing collaboration between academia and industry to accelerate novel synthesis methods.